Spectrum Pharmaceuticals (SPPI) announced that it has appointed Kurt Gustafson as its Executive Vice President, Chief Financial Officer, and Principal Accounting Officer effective immediately.
Gustafson has more than 20 years of experience in corporate finance, with 15 years in senior management roles leading the finance departments of multi-faceted, dynamic and growth oriented biopharmaceutical industry organizations.
Prior to joining Spectrum, Gustafson served as Vice President and Chief Financial Officer at Halozyme Therapeutics, Inc.. Before Halozyme, Gustafson worked at Amgen for over 18 years most recently as Vice President, Finance. During his tenure at Amgen, Gustafson also served as CFO of Amgen International and resided in Zug, Switzerland.
In addition, the company announced that Brett Scott, who formerly held the positions of Senior Vice President and Acting Chief Financial Officer and served as the Company's Principal Accounting Officer, transitioned to the new role of Senior Vice President of Finance, with immediate effect and will report directly to Gustafson.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.